Orthopaedic Surgery - Heterotopic Ossification

Basics

Heterotopic ossification (HO) is the abnormal formation of mature bone within soft tissues where bone does not normally exist, such as muscle, subcutaneous tissue, or around nerves.

It most commonly develops after major trauma, surgery, traumatic brain injury, or spinal cord injury.

Common Sites

The joints most frequently affected are the:

Hip, elbow, and shoulder.

The resulting ectopic bone may progressively restrict joint motion and, in severe cases, bridge the joint and produce ankylosis.

Epidemiology

Heterotopic ossification is less common in children than in adults and occurs more frequently in males.

Incidence

After major neurologic or traumatic injury, HO has been reported in approximately 10–20% of patients, although incidence varies substantially according to the underlying condition and the population studied.

Clinical onset often occurs within the first several months after injury, with an average onset near 2 months in older series.

Risk Factors

Important risk factors include:

Traumatic brain injury, spinal cord injury, major trauma, previous heterotopic ossification, ankylosing spondylitis, osteoarthritis, extensive osteophyte formation, repeated surgery, certain surgical approaches, and trochanteric osteotomy.

Previous HO

A history of heterotopic ossification after prior surgery substantially increases the risk of recurrence with later procedures.

Genetics

No routine genetic test predicts susceptibility to ordinary post-traumatic or postoperative heterotopic ossification.

However, rare inherited disorders of ectopic bone formation have specific genetic causes.

Etiology

Common precipitating conditions include:

Traumatic brain injury, spinal cord injury, direct musculoskeletal trauma, and major orthopaedic surgery.

The precise biologic mechanism involves abnormal differentiation of local progenitor cells toward bone-forming pathways within inflamed soft tissues.

Associated Conditions

Fibrodysplasia Ossificans Progressiva

Fibrodysplasia ossificans progressiva is a rare genetic disorder characterized by progressive heterotopic bone formation.

It is associated with an activating mutation involving the ACVR1 gene.

This disorder differs substantially from ordinary post-traumatic HO.

Osteoma Cutis

Primary osteoma cutis represents another uncommon disorder in which bone forms within the skin or subcutaneous tissues.

Diagnosis

Signs and Symptoms

Early symptoms are often nonspecific.

Patients may develop:

Increasing pain, progressive stiffness, worsening spasticity, muscle guarding, swelling, and decreasing joint range of motion.

Reduced Range of Motion

Loss of motion is often the earliest and most clinically important finding.

A previously mobile joint may become progressively stiff over days to weeks.

Inflammatory Appearance

During the early phase, the affected area may demonstrate erythema, warmth, swelling, and tenderness, sometimes mimicking infection or thrombosis.

Physical Examination

The examiner should carefully document active and passive range of motion.

The joint should also be assessed for:

Swelling, warmth, erythema, tenderness, spasticity, palpable mass formation, and neurovascular changes.

Neurologic Examination

When HO develops near a major nerve, motor and sensory function should be assessed because progressive ossification may cause nerve entrapment.

Laboratory Tests

Alkaline Phosphatase

Serum alkaline phosphatase may become elevated during active heterotopic bone formation.

The level may begin to rise approximately 2–3 weeks after the inciting injury.

However, this test is nonspecific and cannot establish the diagnosis by itself.

Imaging

Plain Radiographs

Radiographic evidence of new bone may become visible approximately 3–6 weeks after injury, although early films can be normal.

Mature and clearly diagnostic ossification may take several months to become obvious.

Bone Scintigraphy

Bone scintigraphy can detect HO earlier than plain radiographs.

The developing lesion demonstrates intense radionuclide uptake during the metabolically active phase.

Historically, bone scans were also used to assess lesion activity before excision.

CT

CT is particularly useful for defining the location, extent, relationship to surrounding bone and neurovascular structures, and operative anatomy.

Zonal Pattern

A characteristic maturation pattern may be seen, with more mature mineralization at the periphery and a relatively lucent or less mineralized center.

This zonal architecture can help distinguish HO from some malignant soft-tissue tumors.

MRI

MRI appearance varies according to lesion maturity.

Early HO may demonstrate low to intermediate signal on T1-weighted images and high signal on T2 or fluid-sensitive sequences, often with surrounding edema.

As ossification matures, the lesion develops signal characteristics resembling cortical and medullary bone.

Preserved Muscle Architecture

Early lesions may show residual muscle fibers coursing through the abnormal tissue, an appearance sometimes described as a texture sign.

Pathological Findings

Early heterotopic ossification produces an intense inflammatory and proliferative response.

The lesion contains myofibroblasts, fibroblasts, osteoblasts, and developing osteoid and bone.

Diagnostic Pitfall

The high cellularity and rapid growth of early HO can resemble a soft-tissue neoplasm histologically.

Recognition of its characteristic zonal maturation pattern is therefore important.

Differential Diagnosis

Important alternatives include:

Septic arthritis, deep infection, thrombophlebitis or deep venous thrombosis, and soft-tissue neoplasm.

Early HO can resemble all of these conditions clinically.

Treatment

General Principles

Most patients are managed nonoperatively.

The main goals are to:

Maintain functional joint motion, control pain, minimize contracture, and prevent further clinically significant ossification when prophylaxis is appropriate.

Physical Therapy

Gentle range-of-motion exercises are important for preserving mobility.

Therapy should emphasize functional motion without forceful manipulation that causes substantial pain or tissue trauma.

Rehabilitation

Treatment may also include positioning, stretching, strengthening of unaffected muscle groups, and strategies to maintain functional independence.

Analgesia

Analgesics may be used for symptomatic relief.

NSAIDs may provide both pain control and prophylactic benefit in selected postoperative settings.

NSAID Prophylaxis

NSAIDs are commonly used to reduce the risk of heterotopic ossification after high-risk procedures or after surgical excision.

Agents may include:

Indomethacin, naproxen, or other appropriate NSAIDs.

A course of approximately several weeks, often around 6 weeks, has traditionally been used.

Limitations

NSAID prophylaxis may be limited by:

Gastrointestinal intolerance, renal disease, bleeding risk, and other contraindications.

A proportion of patients are unable to complete treatment because of adverse effects.

Radiotherapy

Radiotherapy is primarily used as prophylaxis, not as treatment for mature established HO.

Timing

When selected for prevention after surgery, low-dose radiation is generally administered shortly before or within approximately 72 hours after the operative procedure.

Once mature ectopic bone is established, radiation does not remove the lesion.

Surgery

Surgical excision is considered when HO causes substantial disability.

Indications

Potential indications include:

Severe restriction of joint motion, painful mechanical block, contracture, difficulty with sitting or hygiene, nerve entrapment, or major functional impairment.

Timing of Excision

Historically, surgeons waited at least 6 months or longer for maturation before excision.

Modern practice may permit earlier removal when the lesion is sufficiently mature and symptoms justify intervention, particularly when prolonged delay would lead to permanent contracture or functional loss.

The timing should therefore be individualized according to radiographic maturity, neurologic status, joint function, and recurrence risk.

Operative Planning

CT is often useful before surgery to determine the relationship of the ectopic bone to:

Major vessels, nerves, the joint capsule, and surrounding musculature.

Postoperative Prophylaxis

After excision, prophylaxis is commonly used because recurrence is possible.

Options include:

NSAIDs and/or low-dose radiation therapy, depending on patient factors and institutional practice.

Radiation After Resection

If radiation is chosen, it is generally delivered within approximately 72 hours of surgery.

NSAIDs After Resection

A postoperative NSAID course, often lasting approximately 6 weeks, may be prescribed when not contraindicated.

Follow-Up

Patients who undergo surgical excision should be monitored until the wound has healed and functional range of motion has stabilized.

Continued rehabilitation is important to preserve the motion gained at surgery.

Prognosis

Outcome depends on the location, underlying cause, neurologic status, and extent of ossification.

Most patients with non-neurogenic HO retain reasonable function and never require excision.

Neurogenic HO

Patients with traumatic brain or spinal cord injury may develop more extensive lesions and have a greater risk of severe stiffness or ankylosis.

Complications

Loss of Motion

Progressive ectopic bone can substantially restrict joint motion.

Ankylosis

Severe HO may bridge a joint and result in near-complete or complete ankylosis.

Nerve Entrapment

Ectopic bone may surround or compress a major nerve, producing pain, sensory loss, or motor weakness.

Recurrence

HO may recur after surgical excision, particularly in patients with persistent neurologic risk factors or previous recurrent disease.

Patient Monitoring

Serial clinical examinations should document pain, swelling, range of motion, neurologic status, and functional ability.

Radiographs may be obtained at approximately 1–3-month intervals during the first 6 months when progression or maturation needs to be followed.

Imaging frequency should be individualized according to symptoms, lesion location, and whether surgery is being considered.